Updating a meta analysis of intervention research with challenging behaviour

posted by | Leave a comment

Centers for Disease Control and Prevention website.

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Body-mass index and mortality among 1.46 million white adults. Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Estimating deaths attributable to obesity in the United States. Body-mass index and mortality in a prospective cohort of U.

If you have access to a journal via a society or association membership, please browse to your society journal, select an article to view, and follow the instructions in this box.

Contact us if you experience any difficulty logging in.

Chronic disease management: Aim of the intervention was the management of an existing chronic disease. Excluded study design: Study did not use an included design. Literature Search Strategies for Primary Literaturee Methods. Quality Assessment Criteria for Randomized Clinical Trialse Table 1. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. doi:10.1001/jama.295.6.676Pub Med Google Scholar Crossref Acharya NV, Wilton LV, Shakir SA. doi:10.1038/0803323Pub Med Google Scholar Crossref Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. doi:10.1016/j.amepre.20Pub Med Google Scholar Crossref Ackermann RT, Liss DT, Finch EA, et al. doi:10.2105/AJPH.2015.302641Pub Med Google Scholar Crossref Allison DB, Gadde KM, Garvey WT, et al. doi:10.1038/oby.2011.330Pub Med Google Scholar Crossref Anderson AS, Craigie AM, Caswell S, et al. doi:10.1136/bmj.g1823Pub Med Google Scholar Crossref Apovian CM, Aronne L, Rubino D, et al; COR-II Study Group. doi:10.1002/oby.20309Pub Med Google Scholar Crossref Appel LJ, Clark JM, Yeh HC, et al. doi:10.1056/NEJMoa1108660Pub Med Google Scholar Crossref Aronne LJ, Wadden TA, Peterson C, Winslow D, Odeh S, Gadde KM. doi:10.1002/oby.20584Pub Med Google Scholar Crossref Astrup A, Carraro R, Finer N, et al; NN8022-1807 Investigators. doi:10.1038/ijo.2011.158Pub Med Google Scholar Crossref Aveyard P, Lewis A, Tearne S, et al. doi:10.1016/S0140-6736(16)31893-1Pub Med Google Scholar Crossref Bakris G, Calhoun D, Egan B, Hellmann C, Dolker M, Kingma I; Orlistat and Resistant Hypertension Investigators. doi:10.1097/00004872-200211000-00026Pub Med Google Scholar Crossref Befort CA, Klemp JR, Sullivan DK, et al. doi:10.1002/oby.21625Pub Med Google Scholar Crossref Bennett GG, Warner ET, Glasgow RE, et al; Be Fit, Be Well Study Investigators. doi:10.1001/archinternmed.2012.1Pub Med Google Scholar Crossref Bhopal RS, Douglas A, Wallia S, et al. doi:10.1016/S2213-8587(13)70204-3Pub Med Google Scholar Crossref Broom I, Hughes E, Dodson P, Reckless J. Google Scholar Broom I, Wilding J, Stott P, Myers N; UK Multimorbidity Study Group. Pub Med Google Scholar Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA. doi:10.1097/010000170388.61579.4f Pub Med Google Scholar Crossref Cadmus-Bertram L, Nelson SH, Hartman S, Patterson RE, Parker BA, Pierce JP. doi:10.1007/s10865-016-9735-9Pub Med Google Scholar Crossref Chirinos DA, Goldberg RB, Llabre MM, et al. doi:10.1007/s10865-016-9721-2Pub Med Google Scholar Crossref Christian JG, Byers TE, Christian KK, et al. doi:10.1016/20Pub Med Google Scholar Crossref Cussler EC, Teixeira PJ, Going SB, et al. doi:10.1038/oby.2008.19Pub Med Google Scholar Crossref Davidson MH, Hauptman J, Di Girolamo M, et al. doi:10.1001/jama.281.3.235Pub Med Google Scholar Crossrefde Vos BC, Runhaar J, Bierma-Zeinstra SM. doi:10.1007/s00394-013-0505-y Pub Med Google Scholar Crossref Demark-Wahnefried W, Jones LW, Snyder DC, et al. doi:10.1002/cncr.28761Pub Med Google Scholar Crossref Derosa G, Mugellini A, Ciccarelli L, Fogari R. doi:10.1016/S0149-2918(03)80070-XPub Med Google Scholar Crossref Eaton CB, Hartman SJ, Perzanowski E, et al. doi:10.1370/afm.1952Pub Med Google Scholar Crossref Farr OM, Upadhyay J, Gavrieli A, et al. doi:10.2337/db16-0635Pub Med Google Scholar Crossref Fidler MC, Sanchez M, Raether B, et al; BLOSSOM Clinical Trial Group. doi:10.1210/jc.2011-1256Pub Med Google Scholar Crossref Finer N, James WP, Kopelman PG, Lean ME, Williams G. doi:10.1038/0801128Pub Med Google Scholar Crossref Fitzgibbon ML, Stolley MR, Schiffer L, Sharp LK, Singh V, Dyer A. doi:10.1038/oby.2010.47Pub Med Google Scholar Crossref Gadde KM, Allison DB, Ryan DH, et al. Using social and mobile tools for weight loss in overweight and obese young adults (Project SMART): a 2 year, parallel-group, randomised, controlled trial. Waste the waist: a pilot randomised controlled trial of a primary care based intervention to support lifestyle change in people with high cardiovascular risk. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial [published corrections appear in Lancet.

updating a meta analysis of intervention research with challenging behaviour-44updating a meta analysis of intervention research with challenging behaviour-36updating a meta analysis of intervention research with challenging behaviour-24updating a meta analysis of intervention research with challenging behaviour-80

Refer to the USPSTF Procedure Manual for further details. doi:10.7326/0003-4819-138-5-200303040-00007Pub Med Google Scholar Crossref Parker ED, Folsom AR. doi:10.1038/0802437Pub Med Google Scholar Crossref Danaei G, Robins JM, Young JG, Hu FB, Manson JE, Hernán MA. Pub Med Google Scholar Wijnhoven HA, van Zon SK, Twisk J, Visser M. doi:10.1093/gerona/glu005Pub Med Google Scholar Crossref French SA, Folsom AR, Jeffery RW, Williamson DF. doi:10.1093/a009844Pub Med Google Scholar Crossref Williamson DF, Pamuk E, Thun M, Flanders D, Byers T, Heath C. doi:10.1093/a009843Pub Med Google Scholar Crossref Sørensen TI, Rissanen A, Korkeila M, Kaprio J. doi:10.1371/0020171Pub Med Google Scholar Crossref Yaari S, Goldbourt U. doi:10.1093/a009680Pub Med Google Scholar Crossref Courcoulas AP, Goodpaster BH, Eagleton JK, et al. doi:10.1001/jamasurg.2014.467Pub Med Google Scholar Crossref Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. doi:10.1001/jamasurg.2013.3654Pub Med Google Scholar Crossref Sarkhosh K, Switzer NJ, El-Hadi M, Birch DW, Shi X, Karmali S. doi:10.1007/s11695-012-0862-2Pub Med Google Scholar Crossref Sarwer DB, Wadden TA, Moore RH, Eisenberg MH, Raper SE, Williams NN. doi:10.1016/j.soard.20Pub Med Google Scholar Crossref Dawes AJ, Maggard-Gibbons M, Maher AR, et al. doi:10.1001/jama.2015.18118Pub Med Google Scholar Crossref King WC, Chen JY, Belle SH, et al. doi:10.1001/jama.2016.3010Pub Med Google Scholar Crossref Kamvissi-Lorenz V, Raffaelli M, Bornstein S, Mingrone G. doi:10.1007/s11883-017-0642-5Pub Med Google Scholar Crossref Weiss EC, Galuska DA, Kettel Khan L, Gillespie C, Serdula MK. Method: Four effect-size algorithms were calculated for published intervention cases, and results analysed and compared to previous findings by behaviour target, intervention type, and other factors.Results: The evidence largely supports intervention effectiveness, with some inconsistency reflecting the fact that the four metrics assess different aspects of change.Population inclusion criteria: Study was not conducted in an included population. doi:10.1016/S0140-6736(10)60888-4Pub Med Google Scholar Crossref Haapala I, Barengo NC, Biggs S, Surakka L, Manninen P. doi:10.1017/S1368980009005230Pub Med Google Scholar Crossref Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. doi:10.1001/archfami.9.2.160Pub Med Google Scholar Crossref Hill JO, Hauptman J, Anderson JW, et al. doi:10.1093/ajcn/69.6.1108Pub Med Google Scholar Crossref Hunt K, Wyke S, Gray CM, et al. doi:10.1016/S0140-6736(13)62420-4Pub Med Google Scholar Crossref Huseinovic E, Bertz F, Leu Agelii M, Hellebö Johansson E, Winkvist A, Brekke HK. doi:10.3945/ajcn.116.135673Pub Med Google Scholar Crossref Jakicic JM, Otto AD, Lang W, et al. doi:10.1038/oby.2010.122Pub Med Google Scholar Crossref Jansson SP, Engfeldt P, Magnuson A, Pt GL, Liljegren G. doi:10.1186/1756-0500-6-213Pub Med Google Scholar Crossref Jebb SA, Ahern AL, Olson AD, et al. doi:10.1016/S0140-6736(11)61344-5Pub Med Google Scholar Crossref Jeffery RW, Wing RR, Thorson C, et al. doi:10.1037/0022-006X.61.6.1038Pub Med Google Scholar Crossref Jolly K, Lewis A, Beach J, et al. doi:10.1136/bmj.d6500Pub Med Google Scholar Crossref Jones DW, Miller ME, Wofford MR, et al. doi:10.1016/S0895-7061(99)00123-5Pub Med Google Scholar Crossref Kanke S, Kawai T, Takasawa N, Mashiyama Y, Ishii A, Kassai R. doi:10.1186/s12930-015-0022-7Pub Med Google Scholar Crossref Katula JA, Vitolins MZ, Rosenberger EL, et al. Benefits of liraglutide treatment in overweight and obese older individuals with prediabetes. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity. The Women on the Move Through Activity and Nutrition (WOMAN) study: final 48-month results. Prevention of diabetes self-management program (PREDIAS): effects on weight, metabolic risk factors, and behavioral outcomes. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: the Swedish Multimorbidity Study. An internet-based intervention with brief nurse support to manage obesity in primary care (POWe R ): a pragmatic, parallel-group, randomised controlled trial. Weight loss by telemonitoring of nutrition and physical activity in patients with metabolic syndrome for 1 year. Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: a randomized trial. Comparison of commercial and self-initiated weight loss programs in people with prediabetes: a randomized control trial. Lorcaserin, a 5-HT(2C) receptor agonist, reduces body weight by decreasing energy intake without influencing energy expenditure. Weight loss maintenance following a primary care intervention for low-income minority women. Gentle exercise of 40 minutes with dietary counseling is effective in treating metabolic syndrome. Improving management of obesity in primary care: cluster randomised trial. 12-month outcomes and process evaluation of the SHED-IT RCT: an internet-based weight loss program targeting men. The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolemia: a randomized, double-blind, placebo-controlled, multicentre study. Behavioral change during weight loss program and one-year follow-up: Saku Control Obesity Program (SCOP) in Japan. A pragmatic randomised controlled trial in primary care of the Camden Weight Loss (CAMWEL) programme. A web-based lifestyle intervention for women with recent gestational diabetes mellitus: a randomized controlled trial. Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino Diabetes Prevention Project. Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED. Outcomes of a 12-month web-based intervention for overweight and obese men. Long-term weight maintenance after a 17-week weight loss intervention with or without a one-year maintenance program: a randomized controlled trial. Prevention of type 2 diabetes in adults with impaired glucose tolerance: the European Diabetes Prevention RCT in Newcastle upon Tyne, UK. Effects of four maintenance programs on the long-term management of obesity. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. Lifestyle counseling to reduce body weight and cardiometabolic risk factors among truck and bus drivers—a randomized controlled trial. Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) trial: a behavioral weight loss intervention in overweight or obese breast cancer survivors. Randomized trial of a multifaceted commercial weight loss program. The effectiveness of two community-based weight loss strategies among obese, low-income US Latinos. Trial of prevention and reduction of obesity through active living in clinical settings: a randomized controlled trial. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. Text4Diet: a randomized controlled study using text messaging for weight loss behaviors. Enhancing long-term weight loss maintenance: 2 year results from the Keep It Off randomized controlled trial. Using self-determination theory to promote physical activity and weight control: a randomized controlled trial in women. A feasibility randomised controlled trial of a motivational interviewing–based intervention for weight loss maintenance in adults. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Orlistat 60 mg reduces visceral adipose tissue: a 24-week randomized, placebo-controlled, multicenter trial. Multicenter, placebo-controlled trial of lorcaserin for weight management. Efficacy of orlistat 60 mg on weight loss and body fat mass in US Army soldiers. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, Phase II. Cell phone intervention for you (CITY): a randomized, controlled trial of behavioral weight loss intervention for young adults using mobile technology [published correction appears in Obesity (Silver Spring). 2015;39(1):187, 2013;37(11):1514, and 2015;39(1):187]. Population not generalizable or relevant: Included population was not generalizable to a primary care population. doi:10.1016/S0140-6736(11)60205-5Pub Med Google Scholar Crossref Godino JG, Merchant G, Norman GJ, et al. doi:10.1016/S2213-8587(16)30105-XPub Med Google Scholar Crossref Greaves C, Gillison F, Stathi A, et al. doi:10.1186/s12966-014-0159-z Pub Med Google Scholar Crossref Greenway FL, Fujioka K, Plodkowski RA, et al; COR-I Study Group. Weight loss by mobile phone: a 1-year effectiveness study. Orlistat in the long-term treatment of obesity in primary care settings. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trial. Effectiveness of a weight loss intervention in postpartum women: results from a randomized controlled trial in primary health care. The effect of physical activity on 18-month weight change in overweight adults. Interventions for lifestyle changes to promote weight reduction, a randomized controlled trial in primary health care. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Strengthening behavioral interventions for weight loss: a randomized trial of food provision and monetary incentives. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: Lighten Up randomised controlled trial. The effect of weight loss intervention on antihypertensive medication requirements in the Hypertension Optimal Treatment (HOT) study. Interventions for body weight reduction in obese patients during short consultations: an open-label randomized controlled trial in the Japanese primary care setting. One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project [published correction appears in Diabetes Care.

Leave a Reply

Free chat fuck no sighn up